Orphazyme raised €20M in a Series B round in Jan 2015. The company is based in Copenhagen, Denmark. Investors in the round: Aescap, IDInvest Partners, Sunstone Capital. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
